Shanghai, China

Eric Gu


 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2022

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Innovations by Inventor Eric Gu

Introduction

Eric Gu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of four patents. His work focuses on developing efficient synthesis methods for important pharmaceutical compounds.

Latest Patents

One of his latest patents is a synthesis method for cariprazine. This method involves performing an acylation reaction between a specific compound and dimethylcarbamoyl chloride in the presence of an inorganic base. The innovation addresses issues found in prior art, such as long reaction times and large impurities, providing a method that is fast, yields high purity products, and is suitable for commercial production.

Another significant patent is a method for preparing a sitagliptin intermediate via an asymmetrical reduction method. This process utilizes hydrogen and a transition metal catalyst with a chiral phosphine ligand to achieve a high yield and efficiency. The method is environmentally friendly, simple to operate, and suitable for industrial production.

Career Highlights

Eric Gu has worked with prominent companies in the pharmaceutical industry, including Zhejiang Huahai Pharmaceutical Co., Ltd. and Shanghai Syncores Technologies Inc. Ltd. His experience in these organizations has contributed to his expertise in drug synthesis and development.

Collaborations

Throughout his career, Eric has collaborated with talented individuals such as Luning Huang and Boyu Wang. These partnerships have enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Eric Gu is a distinguished inventor whose innovative methods in pharmaceutical synthesis have the potential to significantly impact the industry. His contributions reflect a commitment to advancing drug development processes and improving product quality.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…